Min Fengling,Zhai Lijia,Zhou Wei,Gao Xiaohui,Zhang Lina.. Two cases of chronic myelomonocytic leukemia combined with monoclonal gammopathy of undetermined significance and a literature review. Oncol Transl Med, 2017, 3: 41-46.
Two cases of chronic myelomonocytic leukemia combined with monoclonal gammopathy of undetermined significance and a literature review
Received:October 07, 2016  Revised:February 23, 2017
View Full Text  View/Add Comment  Download reader
KeyWord:myeloproliferative neoplasms (MPN); myelodysplastic syndrome (MDS); monoclonal gammopathy of undetermined significance (MGUS)
Author NameAffiliationE-mail
Min Fengling Department of Hematology, The Affiliated Hospital of Yangzhou University, The First People's Hospital, Yangzhou 225001, China 1014121694@qq.com 
Zhai Lijia Department of Hematology, The Affiliated Hospital of Yangzhou University, The First People's Hospital, Yangzhou 225001, China zhailijia@sina.com 
Zhou Wei Department of Hematology, The Affiliated Hospital of Yangzhou University, The First People's Hospital, Yangzhou 225001, China zhangj@sina.com 
Gao Xiaohui Department of Hematology, The Affiliated Hospital of Yangzhou University, The First People's Hospital, Yangzhou 225001, China hmlygxh@163.com 
Zhang Lina. Department of Hematology, The Affiliated Hospital of Yangzhou University, The First People's Hospital, Yangzhou 225001, China zhanglina0512@163.com 
Hits: 7599
Download times: 8811
Abstract:
      To describe myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) combined with monoclonal gammopathy of undetermined significance (MGUS) in order to investigate the potential association between these 2 diseases. Two cases of confirmed chronic myelomonocytic leukemia (CMML) combined with MGUS were reported. In addition, prior publications of cases with combined MDS or MPN with MGUS were reviewed. The first case was of a 77-year-old man whose routine blood tests showed abnormal hemogram results. The diagnosis was CMML combined with IgM monoclonal gammopathy, and the disease course was 4 years. The CMML gradually progressed and the patient presented with anemia, thrombocytopenia, autoimmune hemolysis, and an increase in the number of immature cells in the bone marrow. Although the MGUS caused fluctuations in the concentrations of IgM, no IgM-associated organ damage was observed. Eventually, this patient died from a lung infection. The second case was of a 78-year-old man who sought treatment because of fever and a cough. An increase in the number of monocytes was discovered in the peripheral blood. Bone marrow smear results suggested obvious active granulocytes and an increase in the percentages of promyelocytes, myelocytes, and metamyelocytes. Unhealthy granulocytes and immature monocytes could also be observed, and the percentage of monocytes was increased. In addition, serum IgG levels were increased, and immunofixation electrophoresis results showed IgG-κ type M proteins. The diagnosis was CMML combined with IgG monoclonal gammopathy. These diseases were stable and follow-up was conducted for 1 year after diagnosis. The cases in this study combined with those that were reviewed in the relevant literature indicate that the presence of these 2 diseases in the same patient might not be a coincidence. The development of the 2 diseases in case 1 was different, and we speculate that they might have had different clonal origins. Whether CMML is a risk factor for MGUS and the role of clonal plasma cells in the occurrence and development of MDS and MDS/ MPN requires further studies on a larger number of cases.
Close